Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	25.34	33.78	26.95
Graham Fair Price	5.21	25.67	24.40
PEG	2150.42	20.10	0.89
Price/Book	26.27	5.30	4.20
Price/Cash Flow	57.79	43.91	27.83
Prices/Earnings	38.25	10.52	7.61
Price/Sales	34.99	9.02	6.68
Price/FCF	57.79	43.91	27.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.23	0.46	0.46
Operating Margin	2.15	0.30	0.29
ROA	-1.20	0.03	0.03
ROE	0.14	0.13	-8.66
ROIC	0.05	0.05	4.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	< 0.005	472.58
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.01	0.04	196.00
EPS QOQ	0.09	< 0.005	-93.86
FCF QOQ	0.02	-0.13	487.10
Revenue QOQ	0.05	0.02	-65.91
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	59.71	60.77	1.77
Days Sales Outstanding (DSO)	41.34	44.71	8.16
Inventory Turnover	1.51	1.48	-1.74
Debt/Capitalization	0.67	0.64	-4.21
Quick Ratio	1.83	1.84	0.41
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.85	15.25	10.08
Cash	6.31	6.38	0.96
Capex	-0.58	-0.13	78.60
Free Cash Flow	2.09	1.84	-11.91
Revenue	8.71	8.97	2.97
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.50	2.51	0.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.42	7.04	-5.14
Naive Interpretation	Member

06 - Financial Health · Bad

Rating